A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Myeloid Leukemia (AML)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack, New York, United States
Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982
Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre, New York, United States
Contact: Study coordinator (Meira Yisraeli Salman, MD) · 646-608-3982

Study leads

Eytan Stein, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Meira Yisraeli Salman, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Tucson, United States · Tucson, United States

Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML

Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Hangzhou, China

Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling

Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Copenhagen, Denmark